Literature DB >> 9141913

Hemodynamic effects of anesthesia in patients with ischemic heart failure chronically treated with angiotensin-converting enzyme inhibitors.

F Ryckwaert1, P Colson.   

Abstract

Anesthesia may induce hemodynamic instability in patients treated with angiotensin-converting enzyme inhibitors (ACEIs). To assess the hemodynamic effects of anesthesia in patients treated (n = 9) or not treated (n = 9) with ACEIs for ischemic left ventricle dysfunction after myocardial infarction, we studied 18 patients scheduled for elective coronary artery bypass graft surgery. Induction of anesthesia with fentanyl (5 micrograms/kg), flunitrazepam (30 micrograms/kg), and pancuronium (100 micrograms/kg) was followed by a significant decrease in mean arterial blood pressure in both groups (-18.6% +/- 8.1% in controls and -25.7% +/- 7.8% in ACEI-treated patients, P = 0.01). In controls, cardiac index and systemic vascular resistance were not significantly altered (-11.2% +/- 9.4% and -16.2% +/- 4.6%, respectively, not significant [NS]). In ACEI-treated patients, cardiac index decreased significantly (-27.3% +/- 11.6%, P = 0.01 from baseline and P = 0.03 when compared with controls), and systemic vascular resistance was unchanged (1.0% +/- 18.7%, NS from baseline and P = 0.04 when compared with controls). Two patients from each group experienced a transient severe hypotensive episode. ACEI treatment in patients with infarction-induced myocardial dysfunction does not increase the incidence of severe hypotension after induction of anesthesia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9141913     DOI: 10.1097/00000539-199705000-00001

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  9 in total

Review 1.  [Preoperative long-term therapy].

Authors:  K Buhre; L de Rossi; W Buhre
Journal:  Anaesthesist       Date:  2005-09       Impact factor: 1.041

2.  [Preoperative administration of angiotensin-converting enzyme inhibitors].

Authors:  U Schirmer; W Schürmann
Journal:  Anaesthesist       Date:  2007-06       Impact factor: 1.041

Review 3.  Minimizing cardiac risk in perioperative practice - interdisciplinary pharmacological approaches.

Authors:  Matthias Bock; Christian J Wiedermann; Johann Motsch; Gerhard Fritsch; Markus Paulmichl
Journal:  Wien Klin Wochenschr       Date:  2011-06-22       Impact factor: 1.704

Review 4.  [Current treatment of chronic heart failure].

Authors:  J Jung; J U Schreiber
Journal:  Anaesthesist       Date:  2003-07-10       Impact factor: 1.041

5.  Preoperative angiotensin-converting enzyme inhibitors and angiotensin receptor blocker use and acute kidney injury in patients undergoing cardiac surgery.

Authors:  Steven G Coca; Amit X Garg; Madhav Swaminathan; Susan Garwood; Kwangik Hong; Heather Thiessen-Philbrook; Cary Passik; Jay L Koyner; Chirag R Parikh
Journal:  Nephrol Dial Transplant       Date:  2013-09-29       Impact factor: 5.992

6.  Perioperative use of renin-angiotensin system inhibitors and outcomes in patients undergoing cardiac surgery.

Authors:  Qian Ding; Zugui Zhang; Hong Liu; Huang Nie; Mark Berguson; Jordan E Goldhammer; Nilas Young; Douglas Boyd; Rohinton Morris; Jianzhong Sun
Journal:  Nat Commun       Date:  2019-09-13       Impact factor: 14.919

7.  Multifactorial Model and Treatment Approaches of Refractory Hypotension in a Patient Who Took an ACE Inhibitor the Day of Surgery.

Authors:  Karan Srivastava; Vikas Y Sacher; Craig T Nelson; John I Lew
Journal:  Case Rep Anesthesiol       Date:  2013-04-10

8.  Consequences of continuing renin angiotensin aldosterone system antagonists in the preoperative period: a systematic review and meta-analysis.

Authors:  Qiong Ling; Yu Gu; Jiaxin Chen; Yansheng Chen; Yongyong Shi; Gaofeng Zhao; Qianqian Zhu
Journal:  BMC Anesthesiol       Date:  2018-02-26       Impact factor: 2.217

9.  Frequency of Intraoperative Hypotension After the Induction of Anesthesia in Hypertensive Patients with Preoperative Angiotensin-converting Enzyme Inhibitors.

Authors:  Fahad Salim; Fazal Khan; Muhammad Nasir; Rashid Ali; Ayesha Iqbal; Amir Raza
Journal:  Cureus       Date:  2020-01-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.